Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. [electronic resource]
Publication details: International journal of hematology-oncology and stem cell research Jul 2018Description: 197-203 p. digitalISSN:- 2008-3009
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.